img

Global Chronic Urticaria Or Hives Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Chronic Urticaria Or Hives Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Chronic Urticaria Or Hives Drug report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Chronic Urticaria Or Hives Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Clinic and Hospital are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Chronic Urticaria Or Hives Drug industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Chronic Urticaria Or Hives Drug key manufacturers include AstraZeneca Plc, Biofrontera AG, ELORAC, Inc., Faes Farma, SA, Genentech, Inc., GlaxoSmithKline Plc, J Uriach Y Compania, S.A., Mabtech Limited and Merck & Co., Inc., etc. AstraZeneca Plc, Biofrontera AG, ELORAC, Inc. are top 3 players and held % sales share in total in 2022.
Chronic Urticaria Or Hives Drug can be divided into GDC-0853, GSK-2646264, BF-Derm-1 and Bilastine, etc. GDC-0853 is the mainstream product in the market, accounting for % sales share globally in 2022.
Chronic Urticaria Or Hives Drug is widely used in various fields, such as Clinic, Hospital and Others,, etc. Clinic provides greatest supports to the Chronic Urticaria Or Hives Drug industry development. In 2022, global % sales of Chronic Urticaria Or Hives Drug went into Clinic filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Chronic Urticaria Or Hives Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


AstraZeneca Plc
Biofrontera AG
ELORAC, Inc.
Faes Farma, SA
Genentech, Inc.
GlaxoSmithKline Plc
J Uriach Y Compania, S.A.
Mabtech Limited
Merck & Co., Inc.
Mycenax Biotech Inc.
Novartis AG
Panacea Biotec Limited
Segment by Type
GDC-0853
GSK-2646264
BF-Derm-1
Bilastine
Others

Segment by Application


Clinic
Hospital
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Chronic Urticaria Or Hives Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Chronic Urticaria Or Hives Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Chronic Urticaria Or Hives Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Chronic Urticaria Or Hives Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Chronic Urticaria Or Hives Drug introduction, etc. Chronic Urticaria Or Hives Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Chronic Urticaria Or Hives Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Chronic Urticaria Or Hives Drug Market Overview
1.1 Chronic Urticaria Or Hives Drug Product Overview
1.2 Chronic Urticaria Or Hives Drug Market Segment by Type
1.2.1 GDC-0853
1.2.2 GSK-2646264
1.2.3 BF-Derm-1
1.2.4 Bilastine
1.2.5 Others
1.3 Global Chronic Urticaria Or Hives Drug Market Size by Type
1.3.1 Global Chronic Urticaria Or Hives Drug Market Size Overview by Type (2018-2034)
1.3.2 Global Chronic Urticaria Or Hives Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Chronic Urticaria Or Hives Drug Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Chronic Urticaria Or Hives Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Chronic Urticaria Or Hives Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Chronic Urticaria Or Hives Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Chronic Urticaria Or Hives Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Chronic Urticaria Or Hives Drug Sales Breakdown by Type (2018-2024)
2 Global Chronic Urticaria Or Hives Drug Market Competition by Company
2.1 Global Top Players by Chronic Urticaria Or Hives Drug Sales (2018-2024)
2.2 Global Top Players by Chronic Urticaria Or Hives Drug Revenue (2018-2024)
2.3 Global Top Players by Chronic Urticaria Or Hives Drug Price (2018-2024)
2.4 Global Top Manufacturers Chronic Urticaria Or Hives Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Chronic Urticaria Or Hives Drug Market Competitive Situation and Trends
2.5.1 Chronic Urticaria Or Hives Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Chronic Urticaria Or Hives Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Chronic Urticaria Or Hives Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Chronic Urticaria Or Hives Drug Market
2.8 Key Manufacturers Chronic Urticaria Or Hives Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Chronic Urticaria Or Hives Drug Status and Outlook by Region
3.1 Global Chronic Urticaria Or Hives Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Chronic Urticaria Or Hives Drug Historic Market Size by Region
3.2.1 Global Chronic Urticaria Or Hives Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Chronic Urticaria Or Hives Drug Sales in Value by Region (2018-2024)
3.2.3 Global Chronic Urticaria Or Hives Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Chronic Urticaria Or Hives Drug Forecasted Market Size by Region
3.3.1 Global Chronic Urticaria Or Hives Drug Sales in Volume by Region (2024-2034)
3.3.2 Global Chronic Urticaria Or Hives Drug Sales in Value by Region (2024-2034)
3.3.3 Global Chronic Urticaria Or Hives Drug Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Chronic Urticaria Or Hives Drug by Application
4.1 Chronic Urticaria Or Hives Drug Market Segment by Application
4.1.1 Clinic
4.1.2 Hospital
4.1.3 Others
4.2 Global Chronic Urticaria Or Hives Drug Market Size by Application
4.2.1 Global Chronic Urticaria Or Hives Drug Market Size Overview by Application (2018-2034)
4.2.2 Global Chronic Urticaria Or Hives Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Chronic Urticaria Or Hives Drug Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Chronic Urticaria Or Hives Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Chronic Urticaria Or Hives Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Chronic Urticaria Or Hives Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Chronic Urticaria Or Hives Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Chronic Urticaria Or Hives Drug Sales Breakdown by Application (2018-2024)
5 North America Chronic Urticaria Or Hives Drug by Country
5.1 North America Chronic Urticaria Or Hives Drug Historic Market Size by Country
5.1.1 North America Chronic Urticaria Or Hives Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Chronic Urticaria Or Hives Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Chronic Urticaria Or Hives Drug Sales in Value by Country (2018-2024)
5.2 North America Chronic Urticaria Or Hives Drug Forecasted Market Size by Country
5.2.1 North America Chronic Urticaria Or Hives Drug Sales in Volume by Country (2024-2034)
5.2.2 North America Chronic Urticaria Or Hives Drug Sales in Value by Country (2024-2034)
6 Europe Chronic Urticaria Or Hives Drug by Country
6.1 Europe Chronic Urticaria Or Hives Drug Historic Market Size by Country
6.1.1 Europe Chronic Urticaria Or Hives Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Chronic Urticaria Or Hives Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Chronic Urticaria Or Hives Drug Sales in Value by Country (2018-2024)
6.2 Europe Chronic Urticaria Or Hives Drug Forecasted Market Size by Country
6.2.1 Europe Chronic Urticaria Or Hives Drug Sales in Volume by Country (2024-2034)
6.2.2 Europe Chronic Urticaria Or Hives Drug Sales in Value by Country (2024-2034)
7 Asia-Pacific Chronic Urticaria Or Hives Drug by Region
7.1 Asia-Pacific Chronic Urticaria Or Hives Drug Historic Market Size by Region
7.1.1 Asia-Pacific Chronic Urticaria Or Hives Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Chronic Urticaria Or Hives Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Chronic Urticaria Or Hives Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Chronic Urticaria Or Hives Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Chronic Urticaria Or Hives Drug Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Chronic Urticaria Or Hives Drug Sales in Value by Region (2024-2034)
8 Latin America Chronic Urticaria Or Hives Drug by Country
8.1 Latin America Chronic Urticaria Or Hives Drug Historic Market Size by Country
8.1.1 Latin America Chronic Urticaria Or Hives Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Chronic Urticaria Or Hives Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Chronic Urticaria Or Hives Drug Sales in Value by Country (2018-2024)
8.2 Latin America Chronic Urticaria Or Hives Drug Forecasted Market Size by Country
8.2.1 Latin America Chronic Urticaria Or Hives Drug Sales in Volume by Country (2024-2034)
8.2.2 Latin America Chronic Urticaria Or Hives Drug Sales in Value by Country (2024-2034)
9 Middle East and Africa Chronic Urticaria Or Hives Drug by Country
9.1 Middle East and Africa Chronic Urticaria Or Hives Drug Historic Market Size by Country
9.1.1 Middle East and Africa Chronic Urticaria Or Hives Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Chronic Urticaria Or Hives Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Chronic Urticaria Or Hives Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Chronic Urticaria Or Hives Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Chronic Urticaria Or Hives Drug Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Chronic Urticaria Or Hives Drug Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 AstraZeneca Plc
10.1.1 AstraZeneca Plc Company Information
10.1.2 AstraZeneca Plc Introduction and Business Overview
10.1.3 AstraZeneca Plc Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 AstraZeneca Plc Chronic Urticaria Or Hives Drug Products Offered
10.1.5 AstraZeneca Plc Recent Development
10.2 Biofrontera AG
10.2.1 Biofrontera AG Company Information
10.2.2 Biofrontera AG Introduction and Business Overview
10.2.3 Biofrontera AG Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Biofrontera AG Chronic Urticaria Or Hives Drug Products Offered
10.2.5 Biofrontera AG Recent Development
10.3 ELORAC, Inc.
10.3.1 ELORAC, Inc. Company Information
10.3.2 ELORAC, Inc. Introduction and Business Overview
10.3.3 ELORAC, Inc. Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 ELORAC, Inc. Chronic Urticaria Or Hives Drug Products Offered
10.3.5 ELORAC, Inc. Recent Development
10.4 Faes Farma, SA
10.4.1 Faes Farma, SA Company Information
10.4.2 Faes Farma, SA Introduction and Business Overview
10.4.3 Faes Farma, SA Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Faes Farma, SA Chronic Urticaria Or Hives Drug Products Offered
10.4.5 Faes Farma, SA Recent Development
10.5 Genentech, Inc.
10.5.1 Genentech, Inc. Company Information
10.5.2 Genentech, Inc. Introduction and Business Overview
10.5.3 Genentech, Inc. Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Genentech, Inc. Chronic Urticaria Or Hives Drug Products Offered
10.5.5 Genentech, Inc. Recent Development
10.6 GlaxoSmithKline Plc
10.6.1 GlaxoSmithKline Plc Company Information
10.6.2 GlaxoSmithKline Plc Introduction and Business Overview
10.6.3 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Products Offered
10.6.5 GlaxoSmithKline Plc Recent Development
10.7 J Uriach Y Compania, S.A.
10.7.1 J Uriach Y Compania, S.A. Company Information
10.7.2 J Uriach Y Compania, S.A. Introduction and Business Overview
10.7.3 J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2018-2024)
10.7.4 J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Products Offered
10.7.5 J Uriach Y Compania, S.A. Recent Development
10.8 Mabtech Limited
10.8.1 Mabtech Limited Company Information
10.8.2 Mabtech Limited Introduction and Business Overview
10.8.3 Mabtech Limited Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Mabtech Limited Chronic Urticaria Or Hives Drug Products Offered
10.8.5 Mabtech Limited Recent Development
10.9 Merck & Co., Inc.
10.9.1 Merck & Co., Inc. Company Information
10.9.2 Merck & Co., Inc. Introduction and Business Overview
10.9.3 Merck & Co., Inc. Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Merck & Co., Inc. Chronic Urticaria Or Hives Drug Products Offered
10.9.5 Merck & Co., Inc. Recent Development
10.10 Mycenax Biotech Inc.
10.10.1 Mycenax Biotech Inc. Company Information
10.10.2 Mycenax Biotech Inc. Introduction and Business Overview
10.10.3 Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Products Offered
10.10.5 Mycenax Biotech Inc. Recent Development
10.11 Novartis AG
10.11.1 Novartis AG Company Information
10.11.2 Novartis AG Introduction and Business Overview
10.11.3 Novartis AG Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Novartis AG Chronic Urticaria Or Hives Drug Products Offered
10.11.5 Novartis AG Recent Development
10.12 Panacea Biotec Limited
10.12.1 Panacea Biotec Limited Company Information
10.12.2 Panacea Biotec Limited Introduction and Business Overview
10.12.3 Panacea Biotec Limited Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Panacea Biotec Limited Chronic Urticaria Or Hives Drug Products Offered
10.12.5 Panacea Biotec Limited Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Chronic Urticaria Or Hives Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Chronic Urticaria Or Hives Drug Industrial Chain Analysis
11.4 Chronic Urticaria Or Hives Drug Market Dynamics
11.4.1 Chronic Urticaria Or Hives Drug Industry Trends
11.4.2 Chronic Urticaria Or Hives Drug Market Drivers
11.4.3 Chronic Urticaria Or Hives Drug Market Challenges
11.4.4 Chronic Urticaria Or Hives Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Chronic Urticaria Or Hives Drug Distributors
12.3 Chronic Urticaria Or Hives Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of GDC-0853
Table 2. Major Company of GSK-2646264
Table 3. Major Company of BF-Derm-1
Table 4. Major Company of Bilastine
Table 5. Major Company of Others
Table 6. Global Chronic Urticaria Or Hives Drug Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Chronic Urticaria Or Hives Drug Sales by Type (2018-2024) & (K Pcs)
Table 8. Global Chronic Urticaria Or Hives Drug Sales Market Share in Volume by Type (2018-2024)
Table 9. Global Chronic Urticaria Or Hives Drug Sales by Type (2018-2024) & (US& Million)
Table 10. Global Chronic Urticaria Or Hives Drug Market Share in Value by Type (2018-2024)
Table 11. Global Chronic Urticaria Or Hives Drug Price by Type (2018-2024) & (USD/Pcs)
Table 12. Global Chronic Urticaria Or Hives Drug Sales by Type (2024-2034) & (K Pcs)
Table 13. Global Chronic Urticaria Or Hives Drug Sales Market Share in Volume by Type (2024-2034)
Table 14. Global Chronic Urticaria Or Hives Drug Sales by Type (2024-2034) & (US$ Million)
Table 15. Global Chronic Urticaria Or Hives Drug Sales Market Share in Value by Type (2024-2034)
Table 16. Global Chronic Urticaria Or Hives Drug Price by Type (2024-2034) & (USD/Pcs)
Table 17. North America Chronic Urticaria Or Hives Drug Sales by Type (2018-2024) & (K Pcs)
Table 18. North America Chronic Urticaria Or Hives Drug Sales by Type (2018-2024) & (US$ Million)
Table 19. Europe Chronic Urticaria Or Hives Drug Sales (K Pcs) by Type (2018-2024)
Table 20. Europe Chronic Urticaria Or Hives Drug Sales by Type (2018-2024) & (US$ Million)
Table 21. Asia-Pacific Chronic Urticaria Or Hives Drug Sales (K Pcs) by Type (2018-2024)
Table 22. Asia-Pacific Chronic Urticaria Or Hives Drug Sales by Type (2018-2024) & (US$ Million)
Table 23. Latin America Chronic Urticaria Or Hives Drug Sales (K Pcs) by Type (2018-2024)
Table 24. Latin America Chronic Urticaria Or Hives Drug Sales by Type (2018-2024) & (US$ Million)
Table 25. Middle East and Africa Chronic Urticaria Or Hives Drug Sales (K Pcs) by Type (2018-2024)
Table 26. Middle East and Africa Chronic Urticaria Or Hives Drug Sales by Type (2018-2024) & (US$ Million)
Table 27. Global Chronic Urticaria Or Hives Drug Sales by Company (2018-2024) & (K Pcs)
Table 28. Global Chronic Urticaria Or Hives Drug Sales Share by Company (2018-2024)
Table 29. Global Chronic Urticaria Or Hives Drug Revenue by Company (2018-2024) & (US$ Million)
Table 30. Global Chronic Urticaria Or Hives Drug Revenue Share by Company (2018-2024)
Table 31. Global Market Chronic Urticaria Or Hives Drug Price by Company (2018-2024) & (USD/Pcs)
Table 32. Global Chronic Urticaria Or Hives Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Chronic Urticaria Or Hives Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Chronic Urticaria Or Hives Drug as of 2022)
Table 35. Date of Key Manufacturers Enter into Chronic Urticaria Or Hives Drug Market
Table 36. Key Manufacturers Chronic Urticaria Or Hives Drug Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Chronic Urticaria Or Hives Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 39. Global Chronic Urticaria Or Hives Drug Sales by Region (2018-2024) & (K Pcs)
Table 40. Global Chronic Urticaria Or Hives Drug Sales Market Share in Volume by Region (2018-2024)
Table 41. Global Chronic Urticaria Or Hives Drug Sales by Region (2018-2024) & (US$ Million)
Table 42. Global Chronic Urticaria Or Hives Drug Sales Market Share in Value by Region (2018-2024)
Table 43. Global Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 44. Global Chronic Urticaria Or Hives Drug Sales by Region (2024-2034) & (K Pcs)
Table 45. Global Chronic Urticaria Or Hives Drug Sales Market Share in Volume by Region (2024-2034)
Table 46. Global Chronic Urticaria Or Hives Drug Sales by Region (2024-2034) & (US$ Million)
Table 47. Global Chronic Urticaria Or Hives Drug Sales Market Share in Value by Region (2024-2034)
Table 48. Global Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 49. Global Chronic Urticaria Or Hives Drug Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 50. Global Chronic Urticaria Or Hives Drug Sales by Application (2018-2024) & (K Pcs)
Table 51. Global Chronic Urticaria Or Hives Drug Sales Market Share in Volume by Application (2018-2024)
Table 52. Global Chronic Urticaria Or Hives Drug Sales by Application (2018-2024) & (US$ Million)
Table 53. Global Chronic Urticaria Or Hives Drug Sales Market Share in Value by Application (2018-2024)
Table 54. Global Chronic Urticaria Or Hives Drug Price by Application (2018-2024) & (USD/Pcs)
Table 55. Global Chronic Urticaria Or Hives Drug Sales by Application (2024-2034) & (K Pcs)
Table 56. Global Chronic Urticaria Or Hives Drug Sales Market Share in Volume by Application (2024-2034)
Table 57. Global Chronic Urticaria Or Hives Drug Sales by Application (2024-2034) & (US$ Million)
Table 58. Global Chronic Urticaria Or Hives Drug Sales Market Share in Value by Application (2024-2034)
Table 59. Global Chronic Urticaria Or Hives Drug Price by Application (2024-2034) & (USD/Pcs)
Table 60. North America Chronic Urticaria Or Hives Drug Sales by Application (2018-2024) (K Pcs)
Table 61. North America Chronic Urticaria Or Hives Drug Sales by Application (2018-2024) & (US$ Million)
Table 62. Europe Chronic Urticaria Or Hives Drug Sales by Application (2018-2024) (K Pcs)
Table 63. Europe Chronic Urticaria Or Hives Drug Sales by Application (2018-2024) & (US$ Million)
Table 64. Asia-Pacific Chronic Urticaria Or Hives Drug Sales by Application (2018-2024) (K Pcs)
Table 65. Asia-Pacific Chronic Urticaria Or Hives Drug Sales by Application (2018-2024) & (US$ Million)
Table 66. Latin America Chronic Urticaria Or Hives Drug Sales by Application (2018-2024) (K Pcs)
Table 67. Latin America Chronic Urticaria Or Hives Drug Sales by Application (2018-2024) & (US$ Million)
Table 68. Middle East and Africa Chronic Urticaria Or Hives Drug Sales by Application (2018-2024) (K Pcs)
Table 69. Middle East and Africa Chronic Urticaria Or Hives Drug Sales by Application (2018-2024) & (US$ Million)
Table 70. North America Chronic Urticaria Or Hives Drug Sales by Country (2018-2024) & (K Pcs)
Table 71. North America Chronic Urticaria Or Hives Drug Sales Market Share in Volume by Country (2018-2024)
Table 72. North America Chronic Urticaria Or Hives Drug Sales by Country (2018-2024) & (US$ Million)
Table 73. North America Chronic Urticaria Or Hives Drug Sales Market Share in Value by Country (2018-2024)
Table 74. North America Chronic Urticaria Or Hives Drug Sales by Country (2024-2034) & (K Pcs)
Table 75. North America Chronic Urticaria Or Hives Drug Sales Market Share in Volume by Country (2024-2034)
Table 76. North America Chronic Urticaria Or Hives Drug Sales by Country (2024-2034) & (US$ Million)
Table 77. North America Chronic Urticaria Or Hives Drug Sales Market Share in Value by Country (2024-2034)
Table 78. Europe Chronic Urticaria Or Hives Drug Sales by Country (2018-2024) & (K Pcs)
Table 79. Europe Chronic Urticaria Or Hives Drug Sales Market Share in Volume by Country (2018-2024)
Table 80. Europe Chronic Urticaria Or Hives Drug Sales by Country (2018-2024) & (US$ Million)
Table 81. Europe Chronic Urticaria Or Hives Drug Sales Market Share in Value by Country (2018-2024)
Table 82. Europe Chronic Urticaria Or Hives Drug Sales by Country (2024-2034) & (K Pcs)
Table 83. Europe Chronic Urticaria Or Hives Drug Sales Market Share in Volume by Country (2024-2034)
Table 84. Europe Chronic Urticaria Or Hives Drug Sales by Country (2024-2034) & (US$ Million)
Table 85. Europe Chronic Urticaria Or Hives Drug Sales Market Share in Value by Country (2024-2034)
Table 86. Asia-Pacific Chronic Urticaria Or Hives Drug Sales by Region (2018-2024) & (K Pcs)
Table 87. Asia-Pacific Chronic Urticaria Or Hives Drug Sales Market Share in Volume by Region (2018-2024)
Table 88. Asia-Pacific Chronic Urticaria Or Hives Drug Sales by Region (2018-2024) & (US$ Million)
Table 89. Asia-Pacific Chronic Urticaria Or Hives Drug Sales Market Share in Value by Region (2018-2024)
Table 90. Asia-Pacific Chronic Urticaria Or Hives Drug Sales by Region (2024-2034) & (K Pcs)
Table 91. Asia-Pacific Chronic Urticaria Or Hives Drug Sales Market Share in Volume by Region (2024-2034)
Table 92. Asia-Pacific Chronic Urticaria Or Hives Drug Sales by Region (2024-2034) & (US$ Million)
Table 93. Asia-Pacific Chronic Urticaria Or Hives Drug Sales Market Share in Value by Region (2024-2034)
Table 94. Latin America Chronic Urticaria Or Hives Drug Sales by Country (2018-2024) & (K Pcs)
Table 95. Latin America Chronic Urticaria Or Hives Drug Sales Market Share in Volume by Country (2018-2024)
Table 96. Latin America Chronic Urticaria Or Hives Drug Sales by Country (2018-2024) & (US$ Million)
Table 97. Latin America Chronic Urticaria Or Hives Drug Sales Market Share in Value by Country (2018-2024)
Table 98. Latin America Chronic Urticaria Or Hives Drug Sales by Country (2024-2034) & (K Pcs)
Table 99. Latin America Chronic Urticaria Or Hives Drug Sales Market Share in Volume by Country (2024-2034)
Table 100. Latin America Chronic Urticaria Or Hives Drug Sales by Country (2024-2034) & (US$ Million)
Table 101. Latin America Chronic Urticaria Or Hives Drug Sales Market Share in Value by Country (2024-2034)
Table 102. Middle East and Africa Chronic Urticaria Or Hives Drug Sales by Country (2018-2024) & (K Pcs)
Table 103. Middle East and Africa Chronic Urticaria Or Hives Drug Sales Market Share in Volume by Country (2018-2024)
Table 104. Middle East and Africa Chronic Urticaria Or Hives Drug Sales by Country (2018-2024) & (US$ Million)
Table 105. Middle East and Africa Chronic Urticaria Or Hives Drug Sales Market Share in Value by Country (2018-2024)
Table 106. Middle East and Africa Chronic Urticaria Or Hives Drug Sales by Country (2024-2034) & (K Pcs)
Table 107. Middle East and Africa Chronic Urticaria Or Hives Drug Sales Market Share in Volume by Country (2024-2034)
Table 108. Middle East and Africa Chronic Urticaria Or Hives Drug Sales by Country (2024-2034) & (US$ Million)
Table 109. Middle East and Africa Chronic Urticaria Or Hives Drug Sales Market Share in Value by Country (2024-2034)
Table 110. AstraZeneca Plc Company Information
Table 111. AstraZeneca Plc Introduction and Business Overview
Table 112. AstraZeneca Plc Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 113. AstraZeneca Plc Chronic Urticaria Or Hives Drug Product
Table 114. AstraZeneca Plc Recent Development
Table 115. Biofrontera AG Company Information
Table 116. Biofrontera AG Introduction and Business Overview
Table 117. Biofrontera AG Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 118. Biofrontera AG Chronic Urticaria Or Hives Drug Product
Table 119. Biofrontera AG Recent Development
Table 120. ELORAC, Inc. Company Information
Table 121. ELORAC, Inc. Introduction and Business Overview
Table 122. ELORAC, Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 123. ELORAC, Inc. Chronic Urticaria Or Hives Drug Product
Table 124. ELORAC, Inc. Recent Development
Table 125. Faes Farma, SA Company Information
Table 126. Faes Farma, SA Introduction and Business Overview
Table 127. Faes Farma, SA Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 128. Faes Farma, SA Chronic Urticaria Or Hives Drug Product
Table 129. Faes Farma, SA Recent Development
Table 130. Genentech, Inc. Company Information
Table 131. Genentech, Inc. Introduction and Business Overview
Table 132. Genentech, Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 133. Genentech, Inc. Chronic Urticaria Or Hives Drug Product
Table 134. Genentech, Inc. Recent Development
Table 135. GlaxoSmithKline Plc Company Information
Table 136. GlaxoSmithKline Plc Introduction and Business Overview
Table 137. GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 138. GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Product
Table 139. GlaxoSmithKline Plc Recent Development
Table 140. J Uriach Y Compania, S.A. Company Information
Table 141. J Uriach Y Compania, S.A. Introduction and Business Overview
Table 142. J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 143. J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Product
Table 144. J Uriach Y Compania, S.A. Recent Development
Table 145. Mabtech Limited Company Information
Table 146. Mabtech Limited Introduction and Business Overview
Table 147. Mabtech Limited Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 148. Mabtech Limited Chronic Urticaria Or Hives Drug Product
Table 149. Mabtech Limited Recent Development
Table 150. Merck & Co., Inc. Company Information
Table 151. Merck & Co., Inc. Introduction and Business Overview
Table 152. Merck & Co., Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 153. Merck & Co., Inc. Chronic Urticaria Or Hives Drug Product
Table 154. Merck & Co., Inc. Recent Development
Table 155. Mycenax Biotech Inc. Company Information
Table 156. Mycenax Biotech Inc. Introduction and Business Overview
Table 157. Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 158. Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Product
Table 159. Mycenax Biotech Inc. Recent Development
Table 160. Novartis AG Company Information
Table 161. Novartis AG Introduction and Business Overview
Table 162. Novartis AG Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 163. Novartis AG Chronic Urticaria Or Hives Drug Product
Table 164. Novartis AG Recent Development
Table 165. Panacea Biotec Limited Company Information
Table 166. Panacea Biotec Limited Introduction and Business Overview
Table 167. Panacea Biotec Limited Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 168. Panacea Biotec Limited Chronic Urticaria Or Hives Drug Product
Table 169. Panacea Biotec Limited Recent Development
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Chronic Urticaria Or Hives Drug Market Trends
Table 173. Chronic Urticaria Or Hives Drug Market Drivers
Table 174. Chronic Urticaria Or Hives Drug Market Challenges
Table 175. Chronic Urticaria Or Hives Drug Market Restraints
Table 176. Chronic Urticaria Or Hives Drug Distributors List
Table 177. Chronic Urticaria Or Hives Drug Downstream Customers
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Chronic Urticaria Or Hives Drug Product Picture
Figure 2. Global Chronic Urticaria Or Hives Drug Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Chronic Urticaria Or Hives Drug Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Chronic Urticaria Or Hives Drug Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of GDC-0853
Figure 6. Global GDC-0853 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of GSK-2646264
Figure 8. Global GSK-2646264 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of BF-Derm-1
Figure 10. Global BF-Derm-1 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of Bilastine
Figure 12. Global Bilastine Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Product Picture of Others
Figure 14. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 15. Global Chronic Urticaria Or Hives Drug Sales by Type (2018-2034) & (US$ Million)
Figure 16. Global Chronic Urticaria Or Hives Drug Sales Market Share by Type in 2022 & 2034
Figure 17. North America Chronic Urticaria Or Hives Drug Sales Market Share in Volume by Type in 2022
Figure 18. North America Chronic Urticaria Or Hives Drug Sales Market Share in Value by Type in 2022
Figure 19. Europe Chronic Urticaria Or Hives Drug Sales Market Share in Volume by Type in 2022
Figure 20. Europe Chronic Urticaria Or Hives Drug Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Chronic Urticaria Or Hives Drug Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Chronic Urticaria Or Hives Drug Sales Market Share in Value by Type in 2022
Figure 23. Latin America Chronic Urticaria Or Hives Drug Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Chronic Urticaria Or Hives Drug Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Chronic Urticaria Or Hives Drug Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Chronic Urticaria Or Hives Drug Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Chronic Urticaria Or Hives Drug Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Chronic Urticaria Or Hives Drug Revenue in 2022
Figure 29. Chronic Urticaria Or Hives Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Product Picture of Clinic
Figure 31. Global Clinic Sales YoY Growth (2018-2034) & (K Pcs)
Figure 32. Product Picture of Hospital
Figure 33. Global Hospital Sales YoY Growth (2018-2034) & (K Pcs)
Figure 34. Product Picture of Others
Figure 35. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 36. Global Chronic Urticaria Or Hives Drug Sales by Application (2018-2034) & (US$ Million)
Figure 37. Global Chronic Urticaria Or Hives Drug Sales Market Share by Application in 2022 & 2034
Figure 38. North America Chronic Urticaria Or Hives Drug Sales Market Share in Volume by Application in 2022
Figure 39. North America Chronic Urticaria Or Hives Drug Sales Market Share in Value by Application in 2022
Figure 40. Europe Chronic Urticaria Or Hives Drug Sales Market Share in Volume by Application in 2022
Figure 41. Europe Chronic Urticaria Or Hives Drug Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific Chronic Urticaria Or Hives Drug Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific Chronic Urticaria Or Hives Drug Sales Market Share in Value by Application in 2022
Figure 44. Latin America Chronic Urticaria Or Hives Drug Sales Market Share in Volume by Application in 2022
Figure 45. Latin America Chronic Urticaria Or Hives Drug Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa Chronic Urticaria Or Hives Drug Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. Chronic Urticaria Or Hives Drug Manufacturing Cost Structure
Figure 49. Chronic Urticaria Or Hives Drug Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries